CEO’s 1.065M RSU Grant Signals SELLAS Life Sciences’ Strong Oncology Outlook
CEO of SELLAS Life Sciences buys 1,065,000 RSUs, signaling confidence in its oncology pipeline and a commitment to long‑term shareholder value.
- SELLAS LIFE SCIENCES GROUP I
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read